v3.26.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Compensation [Abstract]  
Schedule of Company’s Stock Option Activity

The summary of the Company’s stock option activity is as follows:

 

   Number of
Stock Options
   Weighted-Average
Exercise
Price
   Weighted-Average
Remaining
Contractual Life
 
Outstanding at December 31, 2024   329,395   $51.30    5.4 
Granted   8,080    9.60    10 
Exercised   
-
    
-
    
-
 
Forfeited/Expired/Cancelled   (119,926)  $49.94    
-
 
Outstanding at December 31, 2025   217,549   $50.24    4.0 
Exercisable at December 31, 2025   216,521   $49.89    3.9 
Schedule of Company’s Restricted Stock Unit Activity

The summary of the Company’s restricted stock unit activity is as follows:

 

       Weighted-Average   Weighted-Average 
   Number of   Grant Date   Remaining 
   Shares   Fair Value   Vesting Period 
Unvested at December 31, 2024   739   $48.90    0.2 
Granted   39,290    7.39    — 
Vested   (8,263)   6.61    — 
Forfeited   (597)   48.90    — 
Unvested at December 31, 2025   31,169   $7.78    1.4 
Schedule of Recorded Stock-Based Compensation Expense

The summary of the recorded stock-based compensation expense is as follows:

  

   Year Ended December 31, 
   2025   2024 
         
Research and development  $25   $72 
General and administrative   1,464    1,855 
Total stock-based compensation  $1,489   $1,927